Skip to main content
TipRanks
Go Ultimate75% OFF

Boyd C Clarke Insider Profile

4 Followers

Boyd C Clarke, Director at Aldeyra Therapeutics, holds 15.50K shares in Aldeyra Therapeutics (Ticker: ALDX). Most recently, Boyd C Clarke Bought 3,000 shares of Aldeyra Therapeutics on Aug 07, 2014 for an estimated value of $11.04K.

Boyd C Clarke's Trading History

ALDX
Aldeyra Therapeutics
Aug 07, 2014DirectorInformative Buy11.04K$10.37K
ALDX
Insider Shares: 15.50K (0.16%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 07, 2014Informative Buy$11.04K3,000$3.68+115.50%
May 08, 2014Informative Buy$100.00K12,500$8.00+8.00%

You May Also Like

Boyd C Clarke insider profile FAQ

What is the percentage of profitable transactions made by Boyd C Clarke?
The percentage of profitable transactions made by Boyd C Clarke is 100%.
What is the average return per transaction made by Boyd C Clarke?
The average return per transaction made by Boyd C Clarke is 61.70%.
What stocks does Boyd C Clarke hold?
Boyd C Clarke holds: ALDX stocks.
What was Boyd C Clarke’s latest transaction?
Boyd C Clarke’s latest transaction was an Informative Buy of $11.04K.
What was Boyd C Clarke's most profitable transaction?
Boyd C Clarke’s most profitable transaction was an Informative Buy of ALDX stock on August 7, 2014. The return on the trade was 115.50%.
What is Boyd C Clarke's role in Aldeyra Therapeutics?
Boyd C Clarke's role in Aldeyra Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.